Correction: IL‑6‑mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL‑6 receptor‑alpha and activation of STAT3/NRF2 pathway.
作者信息
Hassan Amani, Kungyal Tenzin, Zhou Shufeng, Blati Meryem, Finnson Kenneth, Bertos Nick, Golabi Nahid, Sadeghi Nader, Loganathan Sampath, Philip Anie
机构信息
Divisions of Plastic Surgery, and Surgical and Interventional Sciences, Department of Surgery, McGill University, Montreal, QC, Canada.
Divisions of Thoracic and Upper GI Surgery, Department of Surgery, McGill University, Montreal, QC, Canada.
出版信息
Exp Hematol Oncol. 2025 May 31;14(1):81. doi: 10.1186/s40164-025-00671-2.
Abstract
摘要
相似文献
1
Correction: IL‑6‑mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL‑6 receptor‑alpha and activation of STAT3/NRF2 pathway.
Exp Hematol Oncol. 2025 May 31;14(1):81. doi: 10.1186/s40164-025-00671-2.
2
IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway.
Exp Hematol Oncol. 2025 May 2;14(1):64. doi: 10.1186/s40164-025-00630-x.
3
CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Br J Cancer. 2020 Sep;123(5):833-843. doi: 10.1038/s41416-020-0922-7. Epub 2020 Jun 8.
4
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.
Cancers (Basel). 2022 Jul 28;14(15):3672. doi: 10.3390/cancers14153672.
5
CD109 and squamous cell carcinoma.
J Transl Med. 2018 Apr 6;16(1):88. doi: 10.1186/s12967-018-1461-3.
6
CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity.
JCI Insight. 2021 May 10;6(9):141486. doi: 10.1172/jci.insight.141486.
7
PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1.
Int J Oncol. 2021 Jun;58(6). doi: 10.3892/ijo.2021.5209. Epub 2021 Apr 23.
8
CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Sci Rep. 2019 Nov 6;9(1):16317. doi: 10.1038/s41598-019-50694-z.
9
CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling Axis.
Int J Mol Sci. 2023 Jun 18;24(12):10306. doi: 10.3390/ijms241210306.
10
FLOT2 promotes nasopharyngeal carcinoma progression through suppression of TGF-β pathway via facilitating CD109 expression.
iScience. 2023 Nov 25;27(1):108580. doi: 10.1016/j.isci.2023.108580. eCollection 2024 Jan 19.
本文引用的文献
1
IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway.
Exp Hematol Oncol. 2025 May 2;14(1):64. doi: 10.1186/s40164-025-00630-x.
Zotero 插件